Skip to main content
A

ApicHope Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 300723 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2026-04-23 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300723

About ApicHope Pharmaceutical Group Co.,Ltd

https://www.gdyph.com

ApicHope Pharmaceutical Group Co., Ltd. is a comprehensive enterprise dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products. The company maintains a strategic focus on pediatric medicine, offering a diverse portfolio of specialized formulations for children, including treatments for respiratory, digestive, and infectious diseases. In addition to its pediatric leadership, the group develops medications for chronic conditions, cardiovascular health, and the central nervous system. ApicHope operates advanced production bases that integrate the manufacturing of active pharmaceutical ingredients (APIs) with finished dosage forms. Its R&D efforts are centered on clinical demand and innovative drug delivery systems to enhance therapeutic efficacy. The organization utilizes a robust marketing and distribution infrastructure to deliver healthcare solutions across multiple therapeutic categories.

Recent filings

Filing Released Lang Actions
董事、高级管理人员薪酬管理制度（2026年4月）
Governance Information Classification · 1% confidence The document is a detailed internal policy (“薪酬管理制度”) governing how the company’s board and senior management compensation is determined, approved, paid, and recovered. It outlines governance processes, committee responsibilities, performance measures, and payout rules. This is not an earnings release, financial report, or announcement of a report. It falls squarely under Governance Information (detailed corporate governance rules and internal policies).
2026-04-23 Chinese
一品红药业集团股份有限公司关于召开2025年度股东会的通知
Regulatory Filings
2026-04-23 Chinese
一品红药业集团股份有限公司关于2025年度不进行利润分配的公告
Notice of Dividend Amount Classification · 1% confidence The document is a standalone announcement by the company and its board regarding the 2025 profit distribution plan: specifically that no cash dividends, bonus shares, or capital reserve conversions will be made. It is not a financial report (no full statements), nor a proxy or regulatory narrative, but a notice to shareholders on dividend/profit distribution. Therefore it fits the "Notice of Dividend Amount" category (DIV).
2026-04-23 Chinese
关于对会计师事务所2025年度履职情况的评估报告
Regulatory Filings Classification · 1% confidence The document is a formal announcement by the board on the evaluation of the appointed accounting firm’s 2025 audit performance. It is not the audit opinion itself (AR), nor is it reporting financial results, a management change, or any other narrowly defined category. This type of regulatory/compliance announcement that doesn’t fit a specific category defaults to Regulatory Filings (RNS).
2026-04-23 Chinese
2025年度内部控制自我评价报告
Regulatory Filings Classification · 1% confidence The document is a full “内部控制自我评价报告” (Internal Control Self-Evaluation Report) prepared by the company’s board and management, not merely an announcement or a presentation. It is not a full Annual Report (10-K), nor an earnings release, proxy statement, board change notice, dividend notice, M&A, etc. It is also not an audit opinion by external auditors (AR) but rather management’s compliance report on internal control. It does not fit into any of the highly specific categories (IR, IP, ER, DIV, etc.). As a required compliance filing without a more specific slot, it best falls into the Regulatory Filings (RNS) fallback category.
2026-04-23 Chinese
关于为子公司向银行申请综合授信提供担保的公告
Capital/Financing Update Classification · 1% confidence The document is an official corporate announcement by the board of 一品红药业集团股份有限公司 regarding providing a guarantee for its subsidiaries’ bank credit applications (comprehensive credit lines). This relates directly to the company’s financing activities. It is not a financial statement report, annual/interim report, or proxy/AGM material, nor is it a share issue or merger notice. Under the filing definitions, an announcement of corporate financing arrangements such as guarantees is classified as a Capital/Financing Update (CAP).
2026-04-23 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.